Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era

We measured severe acute respiratory syndrome coronavirus 2 immunoglobulin G responses in 67 patients with hematological malignancies after 2 messenger RNA vaccine doses. Forty-six percent were nonresponders; patients with B-cell chronic lymphocytic leukemia were at highest risk (77% nonresponders)....

Descripción completa

Detalles Bibliográficos
Autores principales: Agha, Mounzer E, Blake, Maggie, Chilleo, Charles, Wells, Alan, Haidar, Ghady
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320282/
https://www.ncbi.nlm.nih.gov/pubmed/34337100
http://dx.doi.org/10.1093/ofid/ofab353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320282/
https://www.ncbi.nlm.nih.gov/pubmed/34337100
http://dx.doi.org/10.1093/ofid/ofab353

Ejemplares similares